Follow
Vinod P Balachandran
Vinod P Balachandran
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Nomograms in oncology: more than meets the eye
VP Balachandran, M Gonen, JJ Smith, RP DeMatteo
The lancet oncology 16 (4), e173-e180, 2015
24682015
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Nature 551 (7681), 512-516, 2017
10092017
Extracellular vesicle and particle biomarkers define multiple human cancers
A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ...
Cell 182 (4), 1044-1061. e18, 2020
8452020
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
M Łuksza, N Riaz, V Makarov, VP Balachandran, MD Hellmann, ...
Nature 551 (7681), 517-520, 2017
6002017
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
VP Balachandran, MJ Cavnar, S Zeng, ZM Bamboat, LM Ocuin, H Obaid, ...
Nature medicine 17 (9), 1094-1100, 2011
5992011
Broadening the impact of immunotherapy to pancreatic cancer: challenges and opportunities
VP Balachandran, GL Beatty, SK Dougan
Gastroenterology 156 (7), 2056-2072, 2019
3582019
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang, E Patterson, J Lihm, ...
Nature 618 (7963), 144-150, 2023
3342023
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
JA Moral, J Leung, LA Rojas, J Ruan, J Zhao, Z Sethna, A Ramnarain, ...
Nature 579 (7797), 130-135, 2020
2792020
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
C Valero, M Lee, D Hoen, K Weiss, DW Kelly, PS Adusumilli, PK Paik, ...
Nature communications 12 (1), 729, 2021
2572021
Toll‐like receptor 9 inhibition confers protection from liver ischemia–reperfusion injury
ZM Bamboat, VP Balachandran, LM Ocuin, H Obaid, G Plitas, ...
Hepatology 51 (2), 621-632, 2010
2202010
Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion
ZM Bamboat, LM Ocuin, VP Balachandran, H Obaid, G Plitas, ...
The Journal of clinical investigation 120 (2), 559-569, 2010
2172010
Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?
JM Creasy, E Sadot, BG Koerkamp, JF Chou, M Gonen, NE Kemeny, ...
Surgery 163 (6), 1238-1244, 2018
2012018
Real-time genomic profiling of pancreatic ductal adenocarcinoma: potential actionability and correlation with clinical phenotype
MA Lowery, EJ Jordan, O Basturk, RN Ptashkin, A Zehir, MF Berger, ...
Clinical Cancer Research 23 (20), 6094-6100, 2017
1832017
Stratification of pancreatic ductal adenocarcinoma: combinatorial genetic, stromal, and immunologic markers
ES Knudsen, P Vail, U Balaji, H Ngo, IW Botros, V Makarov, N Riaz, ...
Clinical Cancer Research 23 (15), 4429-4440, 2017
1812017
The association between tumor mutational burden and prognosis is dependent on treatment context
C Valero, M Lee, D Hoen, J Wang, Z Nadeem, N Patel, MA Postow, ...
Nature genetics 53 (1), 11-15, 2021
1702021
Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection
W Park, J Chen, JF Chou, AM Varghese, KH Yu, W Wong, M Capanu, ...
Clinical Cancer Research 26 (13), 3239-3247, 2020
1692020
Pancreas cancer‐associated weight loss
AE Hendifar, MQB Petzel, TA Zimmers, CS Denlinger, LM Matrisian, ...
The oncologist 24 (5), 691-701, 2019
1572019
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
D Chowell, SK Yoo, C Valero, A Pastore, C Krishna, M Lee, D Hoen, ...
Nature biotechnology 40 (4), 499-506, 2022
1542022
Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a …
A Cercek, T Boerner, BR Tan, JF Chou, M Gönen, TM Boucher, ...
JAMA oncology 6 (1), 60-67, 2020
1522020
KIT oncogene inhibition drives intratumoral macrophage M2 polarization
MJ Cavnar, S Zeng, TS Kim, EC Sorenson, LM Ocuin, VP Balachandran, ...
Journal of Experimental Medicine 210 (13), 2873-2886, 2013
1422013
The system can't perform the operation now. Try again later.
Articles 1–20